masthead-news

News & Events

HTG Completes HTP Product Next-Phase Development Milestone

Expands Potential Market and Study Opportunities for HTG Transcriptome Panel TUCSON, Ariz. , Dec. 22, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology,…

Read More

Posted on:
 

HTG Overview Video

HTG’s proprietary RNA technologies are designed to help better understand disease and treatment options for patients and to unlock a disruptive approach to drug discovery.

Read More

Posted on:
 

Page last updated March 20, 2023